Related Experiment Video

Updated: Aug 6, 2026

Prion Safety Laboratory Swipe Test
06:01

Prion Safety Laboratory Swipe Test

Published on: February 14, 2025

[Creutzfeldt-Jakob disease--the past or the future]

Jerzy Kulczycki1

  • 1I Klinika Neurologiczna, Instytutu Psychiatrii i Neurologii w Warszawie.

Przeglad Epidemiologiczny
|August 17, 2006
PubMed

Insights

Creutzfeldt-Jakob disease (CJD) encompasses four forms: sporadic, familial, iatrogenic, and variant. While sporadic CJD has stable incidence, familial forms stem from PRNP gene mutations, and iatrogenic CJD is preventable. Variant CJD poses significant concerns due to its link with BSE.

Area of Science:

  • Neurology
  • Epidemiology
  • Genetics

Context:

  • Creutzfeldt-Jakob disease (CJD) comprises four primary forms with distinct ethiopathogenesis and epidemiological profiles.
  • Understanding the incidence, genetic underpinnings, and transmission routes of CJD is crucial for public health.
  • Recent advancements provide insights into the long-term outlook and challenges associated with CJD.

Purpose:

  • To present current perspectives on the ethiopathogenesis and epidemiology of the four main forms of CJD.
  • To discuss the stable incidence of sporadic CJD (sCJD) and the unknown reasons behind it.
  • To highlight the genetic basis of familial CJD (fCJD), the preventability of iatrogenic CJD (iCJD), and the concerns surrounding variant CJD (vCJD) linked to BSE.

Summary:

  • Sporadic CJD (sCJD) maintains a consistent incidence of approximately 1 case per million population annually, with its etiology remaining elusive.
  • Familial CJD (fCJD) is an autosomal dominant condition linked to over 40 PRNP gene mutations, exhibiting diverse clinical and neuropathological phenotypes.
  • Iatrogenic CJD (iCJD) has the most favorable epidemiological prognosis due to well-recognized causative medical errors and effective prevention strategies. Variant CJD (vCJD), associated with Bovine Spongiform Encephalopathy (BSE), raises serious global concerns due to its unknown incubation period and prion involvement of reticulo-lymphatic tissues.

Impact:

  • Provides a comprehensive overview of CJD forms, aiding researchers and clinicians in understanding disease dynamics.
  • Highlights the need for continued research into the causes of sCJD and the long-term implications of vCJD.
  • Informs public health strategies for CJD prevention and management, particularly concerning iatrogenic and variant forms.

More Related Videos

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-145105:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...